[Federal Register Volume 87, Number 140 (Friday, July 22, 2022)]
[Notices]
[Pages 43859-43860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-15740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Clinical 
Laboratory Improvement Advisory Committee (CLIAC)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the Clinical Laboratory 
Improvement Advisory Committee (CLIAC). CLIAC, consisting of 20 members 
including the Chair, represents a diverse membership across laboratory 
specialties, professional roles (laboratory management, technical 
specialists, physicians, nurses) and practice settings (academic, 
clinical, public health), and includes a consumer representative.

DATES: Nominations for membership on CLIAC must be received no later 
than September 30, 2022. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected].

FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, CLIAC Management 
Specialist, Deputy Chief, Quality and Safety Systems Branch, Division 
of Laboratory Systems, Center for Surveillance, Epidemiology, and 
Laboratory Services, Office of Public Health Scientific Services, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE, 
Mailstop V24-3, Atlanta, Georgia 30329-4027; Telephone (404) 498-2769; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals 
who have the expertise and qualifications necessary to contribute to 
the accomplishment of the Committee's objectives. Nominees will be 
selected based on expertise in the fields of microbiology (including 
bacteriology, mycobacteriology, mycology, parasitology, and virology), 
immunology (including histocompatibility), chemistry, hematology, 
pathology (including histopathology and cytology), or genetic testing 
(including cytogenetics); from representatives in the fields of medical 
technology, bioinformatics, public health, and clinical practice; and 
from consumer representatives. Federal employees will not be considered 
for membership. Members may be invited to serve for up to four-year 
terms.
    The selection of members is based on candidates' qualifications to 
contribute to accomplishing CLIAC objectives (https://www.cdc.gov/cliac/).
    The U.S. Department of Health and Human Services (HHS) policy 
stipulates that committee membership be balanced in terms of points of 
view represented and the Committee's function. Appointments shall be 
made without discrimination on the basis of age, race, ethnicity, 
gender, sexual orientation, gender identity, HIV status, disability, 
and cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees, requiring the filing of 
financial disclosure reports at the beginning and annually during their 
terms. CDC reviews potential candidates for CLIAC membership each year 
and provides a slate of nominees for consideration to the Secretary of 
HHS for final selection. HHS notifies selected candidates of their 
appointment near the start of the term in July or as soon as the HHS 
selection process is completed. Note that the need for different 
expertise varies from year to year, and a candidate who is not selected 
in one year may be reconsidered in a subsequent year. Candidates should 
submit the following items:

[[Page 43860]]

    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address)
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
Candidates may submit a letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA).
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-15740 Filed 7-21-22; 8:45 am]
BILLING CODE 4163-18-P